M. Lipsitch, S. Riley, S. Cauchemez, A. Ghani, and N. Ferguson, Managing and Reducing Uncertainty in an Emerging Influenza Pandemic, New England Journal of Medicine, vol.361, issue.2, pp.112-115, 2009.
DOI : 10.1056/NEJMp0904380

C. Fraser, C. Donnelly, S. Cauchemez, W. Hanage, and M. Van-kerkhove, Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings, Science, vol.324, issue.5934, pp.1557-1561, 2009.
DOI : 10.1126/science.1176062

M. Van-kerkhove, T. Asikainen, N. Becker, S. Bjorge, and J. Desenclos, Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling, PLoS Medicine, vol.5, issue.6, 2009.
DOI : 10.1371/journal.pmed.1000275.s007

L. White, J. Wallinga, L. Finelli, C. Reed, and S. Riley, Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA, Influenza and Other Respiratory Viruses, vol.208, issue.1, pp.267-276, 2009.
DOI : 10.1111/j.1750-2659.2009.00106.x

Y. Yang, J. Sugimoto, M. Halloran, N. Basta, and D. Chao, The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus, Science, vol.326, issue.5953, pp.729-733, 2009.
DOI : 10.1126/science.1177373

A. Presanis, D. Angelis, D. Hagy, A. Reed, and C. , The New York City Swine Flu Investigation Team The severity of pandemic H1N1 influenza in the United States: a Bayesian analysis, PLoS Medicine, vol.6, 2009.

J. Wu, E. Ma, C. Lee, D. Chu, and P. Ho, The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong, Clinical Infectious Diseases, vol.51, issue.10, pp.1184-1191, 2010.
DOI : 10.1086/656740

S. Riley, K. Kwok, K. Wu, D. Ning, and B. Cowling, Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study, PLoS Medicine, vol.361, issue.6, 2011.
DOI : 10.1371/journal.pmed.1000442.s009

M. Baguelin, K. Hoschler, E. Stanford, P. Waight, and P. Hardelid, Agespecific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation, PLoS ONE, vol.6, 2011.

P. Hardelid, N. Andrews, K. Hoschler, E. Stanford, and M. Baguelin, Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1, Health Technol Assess, vol.14, pp.115-192, 2009.

B. Cowling, M. Lau, L. Ho, S. Chuang, and T. Tsang, The Effective Reproduction Number of Pandemic Influenza, Epidemiology, vol.21, issue.6, pp.842-846, 2010.
DOI : 10.1097/EDE.0b013e3181f20977

J. Wu, B. Cowling, E. Lau, D. Ip, and L. Ho, School Closure and Mitigation of Pandemic (H1N1) 2009, Hong Kong, Emerging Infectious Diseases, vol.16, issue.3, pp.538-541, 2009.
DOI : 10.3201/eid1603.091216

V. Veguilla, K. Hancock, J. Schiffer, P. Gargiullo, and X. Lu, Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations, Journal of Clinical Microbiology, vol.49, issue.6, pp.2210-2215, 2011.
DOI : 10.1128/JCM.00229-11

M. Chen, V. Lee, W. Lim, I. Barr, and R. Lin, 2009 Influenza A(H1N1) Seroconversion Rates and Risk Factors Among Distinct Adult Cohorts in Singapore, JAMA, vol.303, issue.14, pp.1383-1391, 2009.
DOI : 10.1001/jama.2010.404

E. Miller, K. Hoschler, P. Hardelid, E. Stanford, and N. Andrews, Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study, The Lancet, vol.375, issue.9720, pp.1100-1108, 2010.
DOI : 10.1016/S0140-6736(09)62126-7

E. Goldstein, J. Dushoff, J. Ma, J. Plotkin, and D. Earn, Reconstructing influenza incidence by deconvolution of daily mortality time series, Proceedings of the National Academy of Sciences, vol.106, issue.51, pp.21825-21829, 2009.
DOI : 10.1073/pnas.0902958106

J. Papenburg, M. Baz, M. Hamelin, C. Rheaume, and J. Carbonneau, Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus, Clinical and Vaccine Immunology, vol.18, issue.3, pp.520-522, 2011.
DOI : 10.1128/CVI.00449-10

A. Svensson, A note on generation times in epidemic models, Mathematical Biosciences, vol.208, issue.1, pp.300-311, 2007.
DOI : 10.1016/j.mbs.2006.10.010

H. Wearing, P. Rohani, and M. Keeling, Appropriate Models for the Management of Infectious Diseases, PLoS Medicine, vol.30, issue.7, 2005.
DOI : 10.1371/journal.pmed.0020174.sd001

I. Hung, K. To, C. Lee, C. Lin, and J. Chan, Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009, Clinical Infectious Diseases, vol.51, issue.3, pp.274-279, 2009.
DOI : 10.1086/653940

I. Stephenson, K. Nicholson, R. Gluck, R. Mischler, and R. Newman, Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial, The Lancet, vol.362, issue.9400, pp.1959-1966, 2003.
DOI : 10.1016/S0140-6736(03)15014-3

B. Cowling, K. Chan, V. Fang, L. Lau, and H. So, Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households, New England Journal of Medicine, vol.362, issue.23, pp.2175-2184, 2010.
DOI : 10.1056/NEJMoa0911530

URL : https://hal.archives-ouvertes.fr/pasteur-00588909

H. Fineberg, P. Aavitsland, T. Aditama, S. Bino, and E. Carmo, Implementation of the international health regulations (2005): report of the Review Committee on the Functioning of the International Health Regulations (2005) and on Pandemic Influenza A (H1N1) 2009. Geneva: World Health Organization. Available: http://apps.who, 2011.

M. Baguelin, A. Hoek, M. Jit, S. Flasche, and P. White, Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation, Vaccine, vol.28, issue.12, pp.2370-2384, 2010.
DOI : 10.1016/j.vaccine.2010.01.002

J. Ong, M. Chen, A. Cook, H. Lee, and V. Lee, Real-Time Epidemic Monitoring and Forecasting of H1N1-2009 Using Influenza-Like Illness from General Practice and Family Doctor Clinics in Singapore, PLoS ONE, vol.167, issue.4, 2010.
DOI : 10.1371/journal.pone.0010036.s004

D. Bandaranayake, Q. Huang, A. Bissielo, T. Wood, and G. Mackereth, Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic, PLoS ONE, vol.7, issue.10, 2010.
DOI : 10.1371/journal.pone.0013211.s001

G. Mak, P. Choy, W. Lee, A. Wong, and K. Ng, Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong, Journal of Medical Virology, vol.101, issue.11, pp.1809-1815, 2010.
DOI : 10.1002/jmv.21895

P. Buchy, S. Vong, S. Chu, J. Garcia, and T. Hien, Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus, PLoS ONE, vol.5
URL : https://hal.archives-ouvertes.fr/pasteur-00782983

Y. Togo, A. Schwartz, S. Tominaga, and R. Hornick, Cyclooctylamine of Experimental in the Prevention Human Influenza, JAMA: The Journal of the American Medical Association, vol.220, issue.6, pp.837-841, 1972.
DOI : 10.1001/jama.1972.03200060061011